Southern Research in Birmingham is expanding its global reach through a new international collaboration aimed at tackling some of today’s most pressing health challenges.
A new global research partnership
Southern Research has entered into a three-year partnership with London-based Pathogenus Consulting. The agreement, which can be renewed, allows the two organizations to collaborate on global research initiatives and support international biotech companies developing new treatments.
Focus on respiratory diseases and emerging viruses
The collaboration will concentrate on respiratory illnesses such as influenza, RSV and COVID-19, along with other viral diseases including Dengue fever. Pathogenus’ European network will pair with Southern Research’s scientific infrastructure, including its Biosafety Level 2 and 3 laboratories at the Birmingham headquarters.
Expanding impact beyond Birmingham
In addition to infectious diseases, the partnership will also support research in areas like cancer, a longtime focus for Southern Research. Leaders from both organizations said the collaboration strengthens early-phase testing, business development and global market access, positioning Birmingham-based research to make an even broader international impact.
Sign up for the Homely Birmingham newsletter to stay up to date on Birmingham.
